Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments

Código QR

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments

Guardado en:

Detalles Bibliográficos
Autor principal:	Nicholas Greig Evans
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2014
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/d7b8ff29b5104fc29df30c6b8b6e077b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
por: Arturo Casadevall, et al.
Publicado: (2014)

An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to “The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards”
por: Michelle Rozo, et al.
Publicado: (2015)

An Avian H7N1 Gain-of-Function Experiment of Great Concern
por: Simon Wain-Hobson
Publicado: (2014)

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness
por: S. Schultz-Cherry, et al.
Publicado: (2014)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
por: Michael J. Imperiale, et al.
Publicado: (2020)

The Decision to Publish an Avian H7N1 Influenza Virus Gain-of-Function Experiment
por: Terence S. Dermody, et al.
Publicado: (2014)

Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?
por: Marc Lipsitch
Publicado: (2014)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
por: Michael J. Imperiale, et al.
Publicado: (2014)

Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion
por: Arturo Casadevall, et al.
Publicado: (2014)

Biocontainment in Gain-of-Function Infectious Disease Research
por: W. Ian Lipkin
Publicado: (2012)

Zika Virus Focuses the Gain-of-Function Debate
por: Michael J. Imperiale, et al.
Publicado: (2016)

mSphere of Influence: the Value of Simplicity in Experiments and Solidarity among Lab Members
por: Nicholas A. Wallace
Publicado: (2019)

The Apocalypse as a Rhetorical Device in the Influenza Virus Gain-of-Function Debate
por: Arturo Casadevall, et al.
Publicado: (2014)

<italic toggle="yes">mBio</italic> Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to “Conclusive Evidence of Replication of a Plant Virus in Honeybees Is Lacking”
por: Ji Lian Li, et al.
Publicado: (2014)

Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics
por: Nicholas G. Evans
Publicado: (2020)

Reply to “The Underestimation of Global Microbial Diversity”
por: Rudolf Amann, et al.
Publicado: (2016)

The ASM Journals Committee Values the Contributions of Black Microbiologists
por: Patrick D. Schloss, et al.
Publicado: (2020)

The ASM Journals Committee Values the Contributions of Black Microbiologists
por: Patrick D. Schloss, et al.
Publicado: (2020)

The ASM Journals Committee Values the Contributions of Black Microbiologists
por: Patrick D. Schloss, et al.
Publicado: (2020)

The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate
por: Michelle Rozo, et al.
Publicado: (2015)

Falling down the Rabbit Hole: aTRIP Toward Lexiconic Precision in the “Gain-of-Function” Debate
por: W. Paul Duprex, et al.
Publicado: (2014)

Reply to “Understanding the Role of Fungi in Chronic Wounds”
por: Lindsay Kalan, et al.
Publicado: (2016)

Reply to “Precedence for the Structural Role of Flagella in Biofilms”
por: Regine Hengge
Publicado: (2013)

Reply to “Triclocarban and Health: the Jury Is Still Out”
por: Lauren Pischel, et al.
Publicado: (2016)

Reply to “Funding by Lottery: Political Problems and Research Opportunities”
por: Arturo Casadevall, et al.
Publicado: (2016)

The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards
por: Martin Furmanski
Publicado: (2015)

Reply to “Unrealistic Nonphysiological Amounts of Reagents and a Disregard for Published Literature”
por: Alistair J. P. Brown
Publicado: (2015)

Reply to “‘Tolerance’ of Misused Terminology? Enforcing Standardized Phenotypic Definitions”
por: Jakob Haaber, et al.
Publicado: (2015)

Reply to “Statins may decrease the Fatality Rate of MERS Infection”
por: Allison L. Totura, et al.
Publicado: (2015)

Studies in Epistemology & Theory of Values

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: David S. Fedson, et al.
Publicado: (2016)

Reply to “Improving Microbiology Research: the Problems Are Less Statistical and More Biological”
por: Arturo Casadevall, et al.
Publicado: (2016)

Erratum for Mortier and Gayán et al., “Gene Erosion Can Lead to Gain-of-Function Alleles That Contribute to Bacterial Fitness”
por: Julien Mortier, et al.
Publicado: (2021)

Reply to “The Natural Environment May Be the Most Important Source of Antibiotic Resistance Genes”
por: Fabienne Wichmann, et al.
Publicado: (2014)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Daniel E. Goldberg, et al.
Publicado: (2017)

Reply to “Concerns about Transmission Electron Micrographs in Recent Article by Chen and Williams”
por: Henry Neal Williams
Publicado: (2012)

Reply to Jobling, “Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven”
por: Leanid Laganenka, et al.
Publicado: (2021)